Alan Cope, a 69-year-old grandfather from the Midlands, has faced a devastating reality: a diagnosis of Alzheimer’s disease. Having witnessed his 99-year-old mother and three uncles suffer from the same condition, Alan knows all too well the challenges this disease brings.
Determined to make a difference, Alan has joined the innovative READ-OUT study, led by top researchers from the Universities of Oxford and Cambridge. Unlike traditional brain scans, this study aims to develop a blood test that could simplify and improve the diagnosis of Alzheimer’s and other dementias.
Alan’s diagnosis came in October 2022, years after his wife Donna first noticed his memory issues. Now, supported by a major multi-million-pound programme backed by the NIHR, Alzheimer’s Society, and other partners, this research hopes to introduce blood tests into the NHS within five years—making diagnosis more accessible, quicker, and less stressful.
READ MORE: HMRC Increases Personal Tax-Free Allowance by 10% for Married Couples
READ MORE: Walsall Council Housing Scheme Revived with Demolition and £1 Million Funding
The READ-OUT study will not only evaluate blood testing accuracy across diverse ethnic groups and people with varying health backgrounds but also help differentiate types of dementia. This ambitious project has already attracted over 3,100 participants nationwide from NHS memory clinics and mobile testing units.
Despite his diagnosis, Alan remains actively engaged. He enjoys walking their two Labradors, Arthur and Teddy, caring for their ducks and chickens, and spending quality time with his grandchildren. Donna, the couple’s chief financial officer, describes Alan as a gentle and quiet man who is bravely facing the complexities of the disease.
“Alan feels like he’s disappearing,” Donna shares. “It’s heartbreaking, yet he is our rock and the best grandad our kids adore. He’s stopped driving and needs daily support, but his determination inspires us all.”
Susan Bradbury, a clinical research practitioner involved in the study, praises Alan and Donna’s commitment. “Their participation not only supports cutting-edge dementia research but also brings hope for simpler diagnostics through blood testing,” she said.
Alan’s story highlights both the painful reality of Alzheimer’s and the hope that innovative science brings for future generations.